Abiraterone Acetate Significantly Improves Overall Survival Of Patients With Post-Chemotherapy Metastatic Castration-Resistant Prostate Cancer

Links shared publicly online about this topic.

  • 265
    total visits

Abiraterone Acetate Significantly Improves Overall Survival Of Patients With Post-Chemotherapy Metastatic Castration-Resistant Prostate Cancer

medicalnewstoday.com —

A study published today in The New England Journal of Medicine in patients with metastatic advanced prostate cancer following chemotherapy who were treated with abiraterone acetate plus p

View full resource at medicalnewstoday.com

Tags: Cancer, Chemotherapy, Prostate Cancer, Prostate, Men's Health, Medical

  • Share

Most Recently Shared on May 26, 2011 at 2:05 pm By:

mnt_cancer MNT Cancer News

Abiraterone Acetate Significantly Improves Overall Survival Of Patients With Post-Chemotherapy Metastatic Castration-R... http://mnt.to/3Wpg

11 months ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Urology MNT Urology

MNT Prostate News MNT Prostate News

Advertisement